New Milford, CT, United States of America

Jason Alan Mulder

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 7.1

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: Jason Alan Mulder: Innovator in Pharmaceutical Patents

Introduction

Jason Alan Mulder is a notable inventor based in New Milford, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for respiratory conditions. With a total of 8 patents to his name, Mulder's work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents is the invention of Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating Chronic Obstructive Pulmonary Disease (COPD) and asthma. This innovative compound is characterized by its unique formula, which aims to provide effective treatment options for patients suffering from these debilitating conditions.

Career Highlights

Throughout his career, Jason has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development.

Collaborations

Jason has collaborated with talented professionals in his field, including Rogelio Perez Frutos and Thomas Gabriel Tampone. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jason Alan Mulder's contributions to pharmaceutical inventions, particularly in the treatment of respiratory diseases, highlight his role as a significant innovator in the industry. His work continues to inspire advancements in medical treatments and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…